Article

Serum glycoprotein biomarker validation for esophageal adenocarcinoma and application to…

medRxiv · 2018 · Shah, A. K.; Hartel, G.; Brown, I.; Winterford, C.; Na, R.; Le Cao, K.-A.; Spicer, B. A.; Dunstone, M.; Phillips, W. A.; Lord, R. V.; Barbour, A. P.; Watson, D. I.; Joshi, V.; Whiteman, D. C.; Hill, M. M.

Key facts

Title Serum glycoprotein biomarker validation for esophageal adenocarcinoma and application to Barrett’s surveillance
First author Shah, A. K.; Hartel, G.; Brown, I.; Winterford, C.; Na, R.; Le Cao, K.-A.; Spicer, B. A.; Dunstone, M.; Phillips, W. A.; Lord, R. V.; Barbour, A. P.; Watson, D. I.; Joshi, V.; Whiteman, D. C.; Hill, M. M.
Journal medRxiv
Published Mar 13, 2018
DOI 10.1101/281220
Devices mentioned 000734

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature